Recent Findings from the WHI Hormone Therapy Trials: Do They Inform Clinical Decision Making?
Track
:
TRANSLATIONAL
Program Code:
L6-2
Date:
Monday, June 6, 2011
Time:
6:00 PM to 6:30 PM
EST
Location:
Grand Ballroom
SPEAKER
:
JoAnn E Manson, MD,PHD, Brigham & Women's Hosp/Harvard Med Sch Disclosure: Nothing to Disclose
JoAnn E. Manson, MD, DrPH, FACE is Professor of Medicine and the Elizabeth Fay Brigham Professor of Women’s Health at Harvard Medical School and Chief of the Division of Preventive Medicine at Brigham and Women’s Hospital (BWH). She also serves as Co-Director of the Connors Center for Women's Health and Gender Biology at BWH. An endocrinologist and epidemiologist, Dr. Manson has been Principal Investigator of the Boston site of the Women’s Health Initiative (WHI) since its inception in 1993 and serves as PI of the cardiovascular component of the Nurses’ Health Study, the large-scale VITamin D and OmegA-3 TriaL (VITAL), the WAFACS Trial, and the KEEPS Trial. She is actively involved with several large clinical trials and observational studies of cardiovascular disease, including the coronary imaging studies. Dr. Manson has extensively studied the role of endogenous and exogenous hormones in relation to cardiovascular disease, diabetes, and other chronic diseases, the role of biochemical and genetic markers in predicting risk, and the effects of vitamin D and omega-3 fatty acids on health outcomes.